Caris Life Sciences (CAI) Operating Margin (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Operating Margin of 2.44% for Q1 2026, up 5037.0% year-over-year from 0.05% in Q1 2025, and down 91.91% quarter-over-quarter from 30.19% in Q4 2025.
Caris Life Sciences (CAI) Operating Margin (2024 - 2026) Analysis & Trends
Caris Life Sciences' Operating Margin history runs 3 years deep, the most recent figure standing at 2.44% for Q1 2026.
- In Q1 2026, Operating Margin rose 5037.0% year-over-year to 2.44%; the TTM figure through Mar 2026 stood at 11.94% (up 6119.0% YoY), while the FY2025 annual figure was 5.56%, up 6792.0% from the prior year.
- Operating Margin for Q1 2026 stood at 2.44%, down from 30.19% in the prior quarter.
- The five-year high for Operating Margin was 30.19% in Q4 2025, with the low at 66.98% in Q2 2024.
- The 3-year median for Operating Margin is 19.22% (2024), against an average of 20.69%.
- The sharpest annual moves came in 2025 and 2026: Operating Margin jumped 7493 bps in 2025, then surged 5037 bps in 2026.
- Caris Life Sciences' Operating Margin stood at 28.52% in 2024, then surged by 206 bps to 30.19% in 2025, then plunged by 92 bps to 2.44% in 2026.
- Business Quant data shows CAI's Operating Margin at 2.44% in Q1 2026, 30.19% in Q4 2025, and 15.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 31.68% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.06% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -105.20% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.75% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 17.93% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.36% |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 10.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.21% |
| Mar 31, 2026 | 2.44% |
| Dec 31, 2025 | 30.19% |
| Sep 30, 2025 | 15.05% |
| Jun 30, 2025 | -9.92% |
| Mar 31, 2025 | -47.93% |
| Dec 31, 2024 | -28.52% |
| Sep 30, 2024 | -59.87% |
| Jun 30, 2024 | -66.98% |